Bioanalytical Systems, Inc.
(NASDAQ : BASI)

( )
BASI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Servicestothe Health Industry
symbolcompany%chnglast%shortavg$volume
DGXQuest Diagnostics, Inc. 2.23%111.624.3%$193.93m
IQVIQVIA Holdings, Inc. 2.24%151.390.0%$166.97m
LHLaboratory Corp. of America Holdings 1.74%180.942.4%$147.86m
SYNHSyneos Health, Inc. 0.57%51.580.0%$48.40m
AMEHApollo Medical Holdings, Inc. 2.31%16.860.0%$3.02m
NRCNational Research Corp. 0.45%46.950.0%$1.44m
IDXGInterpace Biosciences, Inc. 3.00%3.0922.8%$0.57m
PLXProtalix Biotherapeutics, Inc. -0.28%3.6326.0%$0.29m
PMDPsychemedics Corp. -0.46%4.330.7%$0.11m
BASIBioanalytical Systems, Inc. 0.62%4.860.2%$0.07m

Company Profile

Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.